Victoria Rizk is an Oncology physician affiliated with Tampa General Hospital. OpenAlex indexes 15 publications with 286 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
136 Mountainview Blvd
Basking Ridge, NJ 079203444
Telephone
908-542-3379Provider last certified this registry record 23 Jan 2020.
Industry payments
26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year202572 payments$75,224openpaymentsdata.cms.gov ↗
- Lilly USA, LLCProgram year202531 payments$16,806openpaymentsdata.cms.gov ↗
- SpringWorks Therapeutics, Inc.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
80%Aromatase Inhibitor39.7%Anastrozole68%Letrozole17%Exemestane15%Part D<11 patientsKinase inhibitor28.7%Imatinib Mesylate37%Kisqali25%Votrient16%Verzenio13%Sunitinib Malate10%Part D<11 patients+ 2 more classes in this area
Nervous system
9.5%Gabapentinoids6.3%Gabapentin100%Part D<11 patientsAtypical Antipsychotic3.2%Olanzapine Odt100%Part D<11 patientsMetabolism & gastrointestinal
6.8%Serotonin-3 Receptor Antagonist6.8%Ondansetron Odt100%Part D≥20 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Going HARD at Unresectable Soft Tissue Sarcoma of the Mediastinum
International Journal of Radiation Oncology*Biology*Physics
2024 - Chemotherapy improves distant control in localized high-grade soft tissue sarcoma of the extremity/trunk
Clinical Sarcoma Research
2020 - Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy
Breast Cancer Research and Treatment
2019 - Breast leptomeningeal disease: a review of current practices and updates on management
Breast Cancer Research and Treatment
2019 - Precision medicine approaches for the management of Ewing sarcoma: current perspectives
Pharmacogenomics and Personalized Medicine
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Rodney Landreneau, MD
Tampa General Hospital
Hiram Bezerra, MD
Tampa General Hospital
Demian Obregon, MD
Tampa General Hospital
Douglas Klotch, MD
Tampa General Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”